The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases

被引:24
|
作者
Zhang, LongQing [1 ]
Zhang, Wen [1 ]
Tian, XueBi [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
GLP-1; GLP-1R; CNS diseases; neuroprotection; GLUCAGON-LIKE PEPTIDE-1; BLOOD-BRAIN-BARRIER; GLP-1 RECEPTOR AGONIST; SPINAL-CORD-INJURY; MPTP MOUSE MODEL; CLOZAPINE-ASSOCIATED OBESITY; ALCOHOL-MEDIATED BEHAVIORS; PARKINSONS-DISEASE; HEMORRHAGIC TRANSFORMATION; SYNAPTIC PLASTICITY;
D O I
10.1080/00207454.2021.1924707
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like peptide-1(GLP-1) is a multifunctional polypeptide throughout the lifespan via activating Glucagon-like peptide-1 receptor (GLP-1R).GLP-1 can affect food ingestion, enhance the secretion of insulin from pancreatic islets induced by glucose and be utilized to treat type 2 diabetes mellitus(T2DM).But, accumulating evidences from the decades suggest that activation GLP-1R can not only regulate the blood glucose, but also sustain the homeostasis of intracellular environment and protect neuron from various damaged responses such as oxidative stress, inflammation, excitotoxicity, ischemia and so on. And more and more pre-clinical and clinical studies identified that GLP-1 and its analogues may play a significant role in improving multiple central nervous system (CNS) diseases including neurodegenerative diseases, epilepsy, mental disorders, ischemic stroke, hemorrhagic stroke, traumatic brain injury, spinal cord injury, chronic pain, addictive disorders, other diseases neurological complications and so on. In order to better reveal the relationship between GLP-1/GLP-1R axis and the growth, development and survival of neurons, herein, this review is aimed to summarize the multi-function of GLP-1/GLP-1R axis in CNS diseases.
引用
收藏
页码:473 / 491
页数:19
相关论文
共 50 条
  • [31] A Novel GLP-1R/fHCS Method to Determine the Bioactivity of Glucagon-Like Peptide 1(GLP-1) Analogous Drugs In Vitro
    Wang, Jie
    Lu, Ping
    Zhang, Shengting
    Li, Wanwan
    Ji, Xiuling
    Li, Jing
    Zhang, Hui
    Wei, Yunlin
    Liang, Chenggang
    CURRENT PHARMACEUTICAL ANALYSIS, 2021, 17 (09) : 1197 - 1205
  • [32] GLP-1R AGONISTS AND WEIGHT LOSS Utility of GLP-1R agonists in diabetes requires long term study
    Franco de Oliveira, Jose Mario
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [33] PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist
    Nakamura, Taichi
    Ito, Tetsuhide
    Uchida, Masahiko
    Hijioka, Masayuki
    Igarashi, Hisato
    Oono, Takamasa
    Kato, Masaki
    Nakamura, Kazuhiko
    Suzuki, Koichi
    Jensen, Robert T.
    Takayanagi, Ryoichi
    LABORATORY INVESTIGATION, 2014, 94 (01) : 63 - 78
  • [34] Binding Kinetics, GLP-1 Receptor Internalization, and Effects on Insulin Secretion for GL0034 and Related GLP-1R Agonists
    Carrat, Gaelle
    Nguyen-Tu, Marie-Sophie
    Leclerc, Isabelle
    Thennati, Rajamannar
    Jones, Ben
    Tomas, Alejandra
    Rutter, Guy A.
    DIABETES, 2020, 69
  • [35] Signaling and trafficking dynamics of Estradiol-conjugated GLP-1 at the GLP-1R and subsequent intracellular events mediating estrogen liberation
    Coupland, C.
    Mueller, T.
    Novikoff, A.
    DIABETOLOGIA, 2024, 67 : S541 - S542
  • [36] Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice
    Ruska, Yvette
    Csibi, Andrea
    Doroghazi, Beata
    Szilvasy-Szabo, Anett
    Mohacsik, Petra
    Kornyei, Zsuzsanna
    Denes, Adam
    Kadar, Andrea
    Puskar, Zita
    Hrabovszky, Erik
    Gereben, Balazs
    Wittmann, Gabor
    Fekete, Csaba
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] The Intestines Have a Cardioprotective Role Regulating GLP-1 and GLP-1 Receptor Axis in Hypertensive Cardiomyopathy
    Naruse, Genki
    Kanamori, Hiromitsu
    Iwasa, Masamitsu
    Mikami, Atsushi
    Kawasaki, Masanori
    Nishigaki, Kazuhiko
    Minatoguchi, Shinya
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S205 - S205
  • [38] Prolonged exposure to long-acting GLP-1R agonists selectively desensitizes the β cell response to GLP-1R activation
    Kim, J
    Baggio, L
    Estall, J
    Drucker, D
    DIABETES, 2003, 52 : A323 - A324
  • [39] Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation
    Pabreja, K.
    Mohd, M. A.
    Koole, C.
    Wootten, D.
    Furness, S. G. B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (05) : 1114 - 1128
  • [40] Exploring the GLP-1-GLP-1R axis in pulmonary hypertension
    Jeremic, Dusan
    Nagy, Bence
    Nagaraj, Chandran
    Hoetzenecker, Konrad
    Olschewski, Horst
    Olschewski, Andrea
    JOURNAL OF VASCULAR RESEARCH, 2023, 60 (SUPP1) : 24 - 24